Clinuvel Pharmaceuticals Limited (ASX:CUV)

Clinuvel Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 23, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	551	770	883	734	1,517	1,267
Market Cap Growth	-24.90%	-12.87%	20.40%	-51.63%	19.69%	-23.14%
Enterprise Value	353	596	744	636	1,445	1,210
Last Close Price	11.01	15.32	17.77	14.73	30.43	25.39
PE Ratio	14.31	21.60	28.87	35.14	61.34	84.20
PS Ratio	6.05	8.73	11.28	11.16	31.39	38.92
PB Ratio	2.53	3.79	5.37	5.84	15.36	17.59
P/TBV Ratio	2.54	3.80	5.37	5.85	15.39	17.63
P/FCF Ratio	23.44	24.46	24.62	18.61	82.41	95.30
P/OCF Ratio	23.11	20.77	23.93	18.40	78.75	89.33
EV/Sales Ratio	3.88	6.76	9.50	9.68	29.91	37.16
EV/EBITDA Ratio	6.78	12.09	16.71	17.68	49.73	97.48
EV/EBIT Ratio	6.93	12.28	16.86	17.89	50.60	98.79
EV/FCF Ratio	15.03	18.95	20.73	16.13	78.52	91.00
Debt / Equity Ratio	0.00	0.00	0.01	0.01	0.01	0.02
Debt / EBITDA Ratio	0.01	0.02	0.02	0.03	0.04	0.10
Debt / FCF Ratio	0.03	0.03	0.03	0.03	0.07	0.10
Asset Turnover	0.41	0.42	0.46	0.52	0.51	0.45
Inventory Turnover	0.76	0.77	1.33	3.69	1.87	4.26
Quick Ratio	16.37	8.33	7.02	10.03	11.35	8.88
Current Ratio	17.37	8.81	7.44	10.24	11.81	9.10
Return on Equity (ROE)	19.59%	19.39%	21.09%	18.62%	28.95%	23.29%
Return on Assets (ROA)	14.22%	14.29%	16.34%	17.60%	18.78%	10.64%
Return on Capital (ROIC)	16.01%	16.43%	18.86%	19.59%	20.59%	11.69%
Return on Capital Employed (ROCE)	22.80%	23.60%	26.20%	27.30%	28.60%	16.70%
Earnings Yield	7.04%	4.63%	3.46%	2.84%	1.63%	1.19%
FCF Yield	4.27%	4.09%	4.06%	5.38%	1.21%	1.05%
Dividend Yield	0.45%	0.33%	0.28%	0.27%	0.08%	0.10%
Payout Ratio	6.46%	6.93%	6.46%	5.92%	5.00%	8.13%
Buyback Yield / Dilution	2.63%	1.52%	-0.08%	-1.26%	-1.33%	-1.73%
Total Shareholder Return	3.08%	1.85%	0.21%	-0.99%	-1.25%	-1.63%

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.